Evoke Pharma Inc (STU:EV00)
€ 0.5 0.072 (16.82%) Market Cap: 3.66 Mil Enterprise Value: 3.90 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Q2 2021 Evoke Pharma Inc Earnings Call Transcript

Aug 12, 2021 / 08:30PM GMT
Release Date Price: €11.17 (-0.21%)
Operator

Good day and thank you for standing by. Welcome to the Evoke Pharma's Q2 2021 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today Christine Petraglia from The Ruth Group. Please go ahead.

Christine Petraglia
Christine Petraglia - IR

Thank you. Good afternoon, and welcome to Evoke Pharma's second-quarter 2021 earnings conference call and audio webcast. With me today are Dave Gonyer, Evoke's Chief Executive Officer; and Matt D'Onofrio, Chief Business Officer; as well as Chris Quesenberry, Gimoti's Chief Commercial Officer from EVERSANA.

Earlier today, Evoke issued a press release announcing financial results for the second quarter that ended June 30, 2021. We encourage everyone to read today's press release, as well Evoke's quarterly report on Form 10-Q, which is filed with the SEC. The company's 10-Q report and press release are also available on Evoke's website at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot